Owner Inimex Pharmaceuticals Inc.

Inventors Rozek, Annett; Oreola, Donini; Lentz, Shannon Wayne

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006299682

PCT Pub. Number WO2007/038876

Priority 60/722,962 04.10.05 US; 60/722,959 04.10.05 US; 60/722,958 04.10.05 US

Filing date 4 October 2006

Wipo publication date 12 April 2007

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/48 (2006.01) Enzymes, e.g. ligases (6.) - acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase